Module 1.4: Medicinal Chemistry Flashcards
Oraganic Medicinal Chemistry
SAR adrenergic Agonist: Substitution at R2
Increase in alpha 2 activity
SAR adrenergic Agonist: Substitution at R2
Increases B-activity
Increase CNS & Oral activity
Decrease degradation by MAO
SAR adrenergic Agonist: Aromatic Substitution
3-OH is for Alpha activity
* 4-OH is for Beta activity
* 3&4-OH – both
SAR adrenergic Agonist: Aromatic Substitution
3-OH is for
* 4-OH is for
* 3&4-OH – both
3-OH is for Alpha activity
* 4-OH is for Beta activity
* 3&4-OH – both
SAR adrenergic Agonist: aromatic substitution at3 and 4
___, ____ oral activity
Polar, decreases oral activity
SAR adrenergic Agonist: aromatic sustitution: Metabolized by ___ leading to Shorter DOA
COMT
SAR adrenergic Agonist: aromatic sustitution: Metabolized by COMT leading to _____
Shorter DOA
Adrenergic agonist means
Sympathomimetic activity
SAR of Adrenergoc Agonist:
Lack of 1 OH –__
▪ Absence of both OH – __
resistance to COMT
indirect activity
Adrenergic agonist means
Fight or flight response: Sympathomimetic
SAR adrenergic Agonist: Aromatic Substitution
3-OH replacement by ___ 3-OH replacement by _________ will
→increase Beta activity
→ decrease degradation by COMT
Methanol
SAR adrenergic Agonist: Aromatic Substitution Moving 4-OH to 5-OH will
___
____
→increase B2 activity
→ decrease degradation by COMT
SAR adrenergic Agonist: Aromatic Substitution
Moving____ will
→increase B2 activity
→ decrease degradation by COMT
4-OH to 5-OH
SAR of Adrenergoc Agonist:
____ – resistance to COMT
_____- indirect activity
Lack of 1 OH
Absence of both OH –
SAR of Adrenergoc ANTAGONIST: Alpha blocker
pharmacopore
Quinazoline
SAR of Adrenergoc ANTAGONIST: ____
Sympatholitic
SAR of Adrenergoc ANTAGONIST: Alpha blocker
Prototype
Prazosin
SAvR of Adrenergoc ANTAGONIST: Alpha blocker
____ is essential for the activity
4-amino group
SAR of Adrenergoc ANTAGONIST: Alpha blocker
__ 2nd position of quinazoline
Piperazine
SAR of Adrenergoc ANTAGONIST: Alpha blocker
Positions __, __, __, __ can be varied
5,6,7,8
SAR of Adrenergoc ANTAGONIST: Alpha blocker
Can be any heterocyclic ring
Piperazine
SAR of Adrenergoc ANTAGONIST: Alpha blocker
examples
Piperazine and piperadine
SAR of Adrenergoc ANTAGONIST: BETA blocker
Pharmacopore
Aryloxopropanol
SAR of Adrenergoc ANTAGONIST: BETA blocker
Prototype
Propranolol
SAR of Adrenergoc ANTAGONIST: BETA blocker
____ can be varied with other heteroaromatic ring
Aryl ring
SAR of Adrenergoc ANTAGONIST: BETA blocker
__, and __ both beneficial to activity
Branching & extension
SAR of Cholinergic agonists: ___
parasympathomimetic
SAR of Cholinergic agonists: Direct Acting
Pharmacopore
Acetylcholine
SAR of Cholinergic agonists: Direct Acting
Prototype
Acetylcholine
SAR of Cholinergic agonists: Direct Acting
Acetylcholine components Functional group
- Acetoxy/Ester Portion
- Ethylene Bridge
- Quaternary Nitrogen
All are essential for the activity – overall size of the molecule should not be altered
SAR of Cholinergic agonists: Direct Acting
Acetylcholine components Functional group
All are essential for the activity – overall size of the molecule ___ be altered
should not
SAR of Cholinergic agonists: Direct Acting
_____
* The methyl group cannot be extended
but may be replaced with NH2 (Carbamate)
* Not easily hydrolyzed
* Longer DOA
Acetoxy/Ester Portion
SAR of Cholinergic agonists: Direct Acting
Acetoxy/Ester Portion
* ____ cannot be extended
but may be replaced with NH2
The methyl group
SAR of Cholinergic agonists: Direct Acting
_____ cannot be altered
Ammonium group
SAR of Cholinergic agonists: Direct Acting
Acetoxy/Ester Portion
Not easily ____
Longer ___
hydrolyzed
DOA
SAR of Cholinergic agonists: Direct Acting
___: Addition of methyl increase muscarinic selectivity; longer duration of action
choline/ ethylene bridge
SAR of Cholinergic agonists: INDIRECT Acting
- Prototype: Physostigmine
* Equivalent to the ester of acetylcholine (recognize by AChE but not easily hydrolyzed by the enzyme
Carbamate
SAR of Cholinergic agonists: Direct Acting
choline/ ethylene bridge : Addition of ___ increase muscarinic selectivity; longer duration of action
methyl
SAR of Cholinergic agonists: INDIRECT Acting
Prototype of Carbamate
Physostigmine
SAR of Cholinergic agonists: INDIRECT Acting
Carbamate:
Equivalent to the ____ (recognize by AChE but not easily hydrolyzed by the enzyme)
ester of acetylcholine
SAR of Cholinergic agonists: INDIRECT Acting
Carbamate: has a ___ group
amino group
SAR of Cholinergic agonists: INDIRECT Acting
Carbamate: has an amine group to prevent ____
hydrolysis
SAR of Cholinergic ANTAGONIST:
_____
Prototype drug: Atropine
Contains Tropane ring system
Amino Alcohols Esters SAR
SAR of Cholinergic ANTAGONIST:
Amino Alcohols Esters SAR
Prototype drug: ___
Contains Tropane ring system
Atropine
SAR of Cholinergic ANTAGONIST:
Amino Alcohols Esters SAR
Prototype drug: Atropine
Contains _____system
Tropane ring
SAR of Anxiolytics, Sedative, and Hypnotic agents
Benzodiazepine
MOA: Increase ______________ of opening of GABA-gated Chloride Channel
SAR of Anxiolytics, Sedative, and Hypnotic agents
__
C=O – is essential for the activity
* Fused triazole or Imidazole ring at positions 1 and 2 – increases activity
* Fused ring – Imidazole = Midazolam
Benzodiazepine
SAR of Anxiolytics, Sedative, and Hypnotic agents
____
MOA: Increase frequency of opening of GABA-gated Chloride Channel
Benzodiazepine
SAR of Anxiolytics, Sedative, and Hypnotic agents
Benzodiazepine
MOA: Increase frequency of opening of ____
GABA-gated Chloride Channel
SAR of Anxiolytics, Sedative, and Hypnotic agents
Benzodiazepine
MOA: Increase ______________ of opening of GABA-gated Chloride Channel
Frequency
SAR of Anxiolytics, Sedative, and Hypnotic agents
Benzodiazepine
___ – is essential for the activity
* Fused triazole or Imidazole ring at positions 1 and 2 – increases activity
* Fused ring – Imidazole = Midazolam
C=O Carboxyl
SAR of Anxiolytics, Sedative, and Hypnotic agents
Benzodiazepine
C=O – is essential for the activity
_____ or Imidazole ring at positions 1 and 2 – increases activity
* Fused ring – Imidazole = Midazolam
- Fused triazole
SAR of Anxiolytics, Sedative, and Hypnotic agents
Benzodiazepine
C=O – is essential for the activity
* Fused triazole or ____ at positions 1 and 2 – increases activity
* Fused ring – Imidazole = Midazolam
Imidazole ring
SAR of Anxiolytics, Sedative, and Hypnotic agents
Benzodiazepine
C=O – is essential for the activity
* Fused triazole or Imidazole ring at positions ____ – increases activity
* Fused ring – Imidazole = Midazolam
1 and 2
SAR of Anxiolytics, Sedative, and Hypnotic agents
Benzodiazepine
C=O – is essential for the activity
* Fused triazole or Imidazole ring at positions 1 and 2– _____
* Fused ring – Imidazole = Midazolam
increases activity
SAR of Anxiolytics, Sedative, and Hypnotic agents
Benzodiazepine
C=O – is essential for the activity
* Fused triazole or Imidazole ring at positions 1 and 2– increases activity
*______ – Imidazole = Midazolam
Fused ring
SAR of Anxiolytics, Sedative, and Hypnotic agents
Benzodiazepine
SAR of Anxiolytics, Sedative, and Hypnotic agents
Benzodiazepine
______ substitution with EWG increases the
activity= increases CNS Activity
X - Carbon7
SAR of Anxiolytics, Sedative, and Hypnotic agents
Benzodiazepine
X: substitution with EWG increases the
activity= _______
increases CNS Activity
SAR of Anxiolytics, Sedative, and Hypnotic agents
Benzodiazepine= _____ group – increases the activity
* Prime numbering in the aromatic ring
indicates the possible attachment of
substituents
* 2’ or 2’ and 6’ – substitution with EWG will
increase the drug activity
* 4’ substitution – will decrease the activity
5-phenyl
SAR of Anxiolytics, Sedative, and Hypnotic agents
Benzodiazepine= 5-phenyl group – ___
* Prime numbering in the aromatic ring
indicates the possible attachment of
substituents
* 2’ or 2’ and 6’ – substitution with EWG will
increase the drug activity
* 4’ substitution – will decrease the activity
increases the activity
SAR of Anxiolytics, Sedative, and Hypnotic agents
Benzodiazepine= 5-phenyl group – increases the activity
* ______ numbering in the aromatic ring
indicates the possible attachment of
substituents
* 2’ or 2’ and 6’ – substitution with EWG will
increase the drug activity
* 4’ substitution – will decrease the activity
Prime
SAR of Anxiolytics, Sedative, and Hypnotic agents
Benzodiazepine= 5-phenyl group – increases the activity
* Prime numbering in the aromatic ring indicates the possible attachment of substituents
*______ – substitution with EWG will
increase the drug activity
* 4’ substitution – will decrease the activity
2’ or 2’ and 6’
SAR of Anxiolytics, Sedative, and Hypnotic agents
BenSAR of Anxiolytics, Sedative, and Hypnotic agents
Benzodiazepine= 5-phenyl group – increases the activity
* Prime numbering in the aromatic ring
indicates the possible attachment of
substituents
* 2’ or 2’ and 6’ – substitution with EWG will
increase the drug activity
*______ – will decrease the activityzodiazepine= 5-phenyl group – increases the activity
4’ substitution
SAR of Anxiolytics, Sedative, and Hypnotic agents
Benzodiazepine= 5-phenyl group – increases the activity
* Prime numbering in the aromatic ring
indicates the possible attachment of
substituents
* 2’ or 2’ and 6’ – substitution with EWG will
increase the drug activity
* 4’ substitution – will ____ the activity
decrease
SAR of Anxiolytics, Sedative, and Hypnotic agents
Barbiturates MOA: Increase duration of
____
opening of GABA-gated Chloride Channel
SAR of Anxiolytics, Sedative, and Hypnotic agents
Barbiturates MOA: Increase _____________ of
opening of GABA-gated Chloride Channel
duration
SAR of Anxiolytics, Sedative, and Hypnotic agents
Barbiturates
_______
* Increase lipophilicity
* Quick Onset and Short DOA
R1 Alkyl substitution
SAR of Anxiolytics, Sedative, and Hypnotic agents
Barbiturates
R1 Alkyl substitution
*___
* Quick Onset and Short DOA
Increase lipophilicity
SAR of Anxiolytics, Sedative, and Hypnotic agents
Barbiturates
R1 Alkyl substitution
* Increase lipophilicity
* Quick Onset and ___
Short DOA
SAR of Anxiolytics, Sedative, and Hypnotic agents
Barbiturates
______
* Increase lipophilicity
* Ultra-short acting effect
Replacing oxygen w/ sulfur
SAR of Anxiolytics, Sedative, and Hypnotic agents
Barbiturates
R5 Alkyl or Aryl (Aromatic ring)
substitution
* Increase ____
lipophilicity
SAR of antipsychotic and antidepressant drug
Antipsychotic :
_______
* Increases the potency
R2 EWG substitution
SAR of antipsychotic and antidepressant drug
Antipsychotic :
R2 EWG substitution
* _____
Increases the potency
SAR of antipsychotic and antidepressant drug
Antipsychotic :
3 degree Amine
* ____ must have a
N-containing side chain on the ring N and must be separated by at least 3C!
* Essential for the activity
R-group
SAR of antipsychotic and antidepressant drug
Antipsychotic :
3 degree Amine
* R-group must have a
___ side chain on the ring N and must be separated by at least 3C!
* Essential for the activity
N-containing
SAR of antipsychotic and antidepressant drug
Antipsychotic :
3 degree Amine
* R-group must have a
N-containing side chain on the ring N and must be separated by at least ___
* Essential for the activity
3C!
SAR of antipsychotic and antidepressant drug
Antipsychotic :
3 degree Amine
* R-group must have a
N-containing side chain on the ring N and must be separated by at least 3C!
* ______
Essential for the activity
SAR of antipsychotic and antidepressant drug
______
SAR is somehow related to antipsychotic
Antidepressants:
SAR of antipsychotic and antidepressant drug
Antipsychotic :
Tertiary amine is essential for the activity of___, and ___
antihistamine and anticholinergic
SAR of antipsychotic and antidepressant drug
_____
The ring side and side chain Nitrogen is separated by 3C
Antidepressants
SAR of antipsychotic and antidepressant drug
___
The Central Ring System makes the two aromatic rings “skewed” which is required for the activity
Antidepressants
Isolated from Papaver
somniferum
SAR of Opiod Analgesic
What is the pharmacopore of SAR of Opiod Analgesic
aromatic ring
Phenol
tertiary amine
Opiod Analgesic SAR: It is the aromatic ring
Ring A
Opiod Analgesic SAR: ___ + 3-OH is the phenol
Ring A
Opiod Analgesic SAR: contains the tertiary amine
Ring D
Opiod Anlagesic: Addition of ___ to 3C will result to Codeine
Methyl
Opiod Anlagesic: Addition of methyl to 3C will result to _____
Codeine
Opiod Anlagesic: Addition of methyl to 3C will result to codeine
Addition of either ___or ___ will decrease the activity
methyl
Opioid Analgesic SAR:
▪______ removal of a particular part of the molecule and observe its effect to the activity
Drug dissection:
Opioid Analgesic SAR:
Drug dissection: removal of a 6-OH or Alkene at position 7 or 8= _____
Retained activity
Opioid Analgesic SAR: Drug dissection: removal of ring D= ____
Decreased activity
Opioid Analgesic SAR:
Drug dissection: removal of ring E
* retained activity
* Will result to ___ such as
Levorphanol which are more potent
and longer acting than Morphine
morphinans
Opioid Analgesic SAR:
Drug dissection: removal of ring E
* _____
* Will result to morphinans such as
Levorphanol which are more potent
and longer acting than Morphine
Retained activity
Opioid Analgesic SAR:
Drug dissection: ______
* Retained activity
* Will result to morphinans such as Levorphanol which are more potent and longer acting than Morphine
removal of ring E
Opiod Analgesic: Drug dissection: removal of ring ___
* Retained activity
* Will result to Benzomorphans such as Pentazocine
C and D
also E
Opiod Analgesic: Drug dissection: removal of ring C and D
* _____
* Will result to Benzomorphans such as
Pentazocine
Retained activity
Opiod Analgesic: Drug dissection: removal of ring C and D
* Retained activity
* Will result to ___ such as
Pentazocine
Benzomorphans
Opiod Analgesic: Drug dissection: removal of ring __, __, and __
* Retained activity
* Will result to 4 phenylpiperidines such as Fentanyl (more flexible molecules)
B, C and E
Opiod Analgesic: Drug dissection: removal of ring C and D
* Retained activity
* Will result to Benzomorphans such as
___
Pentazocine
Opiod Analgesic: Drug dissection: removal of ring B, C and E
* ___
* Will result to 4 phenylpiperidines such as Fentanyl (more flexible molecules)
Retained activity
Opiod Analgesic: Drug dissection: removal of ring B, C and E
* Retained activity
* Will result to 4 ___ such as Fentanyl (more flexible molecules)
phenylpiperidines
Opiod Analgesic: Drug dissection: removal of ring B, C and E
* Retained activity
* Will result to 4 phenylpiperidines such as __ (more flexible molecules)
Fentanyl
It is more potent than benzodiazepines
Barbiturates
it is 100x more potent than morphine
fentanyl
Pharmacopore of what
Lipophilic ring that may be
substituted
* A linker (ester or amide)
* Amine group that is usually
tertiary amine
SAR of Local anesthetic:
SAR of Local anesthetic:
What Functional group is the linker
A linker is an ester and amide
SAR of Local anesthetic: __ group that is usually tertiary amine
amine group
Contain a system of conjugated double bonds in macrocyclic lactone rings. They differ from erythromycin in that they are larger and contain the conjugated –ene system of double bonds
Polyenes
this MOA: Binds with ergosterol and acts as false membrane component causing membrane disruption belongs to
Antifungal agents: Polyenes
Polyenes Contain a system of ___ in macrocyclic lactone rings. They differ from erythromycin in that they are larger and contain the conjugated –ene system of double bonds
conjugated double bonds
Polyenes Contain a system of conjugated double bonds in ___. They differ from erythromycin in that they are larger and contain the conjugated –ene system of double bonds
macrocyclic lactone rings
Polyenes Contain a system of conjugated double bonds in macrocyclic lactone rings. They differ from _____ in that they are larger and contain the conjugated –ene system of double bonds
erythromycin
Polyenes Contain a system of conjugated double bonds in macrocyclic lactone rings. They differ from erythromycin in that they are larger and contain the ___ of double bonds
conjugated –ene system
Polyenes:
26-membered ring-polyenes: ___
natamycin
Polyenes:
38-membered ring-polyenes: ____, ____
nystatin, and amphotericin B
Polyenes: MOA: Binds with ___ and acts as false membrane component causing membrane disruption
ergosterol
Source of Amphotericin B
Streptomyces nodosus
Antifungal agents that is Indicated for the treatment of severe life-threatening infections; systemic mycoses
Amphotericin
amphotericin B is indicated for the txt of severe life-threatening infections; systemic mycoses
Amphotericin B
It is a antifungal agents that is Not absorbed systemically when
given orally and is too toxic to be
given parenterally. Hence, is
administered topically
Nystatin
Source of nystatin is ___
Streptomyces noursei
Antifungal agents:
Azole: Synthetic antifungal agents that can achieve ____ for the infecting fungus over host
selectivity
Polyenes is similar to ____ (Macrolides)
Erythromycin
Antifungal agents thatmust not br given IM
Amphotericin B
In griseofulvin, when there is increase in fats = ____ in absorption
increase
Antifungal agents
MOA ofAllylamine and related compounds
MOA: Inhibits ergosterol synthesis via inhibiting squalene epoxidase.
aNTIFUNGAL AGENT that is not absorbed systematically weh given orally and is toxic ____
not absorbedsystematically - orally
toxic - parenterally
Antifungal agents:
Azole:
___ functionality confers high lipophilicity except Fluconazole
Non-polar
Antifungal agents:
___ Isolated from Penicillum griseofulvum
griseofulvin
Griseofulvin oral bioavailability is ____
poor
Antifungal agents:
Used for ringworm infections
Griseofulvin
Antifungal agents:
______ MOA : Inhibits ergosterol synthesis via inhibiting squalene epoxidase
Allylamine and related compounds
wha is the MOA of griseofulvin
Mitotic spindle poison
Antifungal agents
MOA: Mitotic spindle poison
Griseovulfin
Antifungal agents
Example of Allylamine and related compounds
Examples: Naftiline, Terbinafine,
Tolnaftate (not an allylamine)
Antifungal agents:
____
▪ MOA: Inhibits lanosterol 14-a-demethylase
* High Conc: Fungicidal
* Low Conc: Fungistatic
Azole
Antifungal agents:
Azole
▪ MOA: _____
* High Conc: Fungicidal
* Low Conc: Fungistatic
Inhibits lanosterol 14-alpha demethylase
Antifungal agents:
Azole
▪ MOA: Inhibits lanosterol 14-a-demethylase
* High Conc: _____
* Low Conc: ____
Fungicidal
Fungistatic
Antifungal agents:
______
▪ MOA: Inhibits lanosterol 14-a-demethylase
Azole
Antifungal agents:
____Synthetic antifungal agents that can achieve selectivity for the infecting fungus over host
Azole
Antifungal agents:
_____: Must contain weakly basic imidazole or triazole ring bonded by a nitrogen-carbon linkage to the rest of the structure
Azole
Antifungal agents:
Azole: Must contain _______ or triazole ring bonded by a nitrogen-carbon linkage to the rest of the structure
weakly basic imidazole
Antifungal agents:
Azole: The most potent antifungal azoles possess ____ with at least one of which is halogen substitute
two or three aromatic rings
Antifungal agents:
Azole: Halogen atom that yields most potency is ____
fluorine
Antifungal agents:
Azole:
Non-polar functionality confers ___ except Fluconazole
high lipophilicity
Antifungal agents:
Azole: Presumably, the large non polar portion of these molecules mimics the non-polar steroidal part of ___
lanosterol 14-a-demethylase
Antifungal agents:
Azole:
▪ Substitution at other positions of the ring yields ____
inactive compounds.
Antifungal agents:
Azole: Non-polar functionality confers high lipophilicity except ___
Fluconazole
Antifungal agents:
Azole: Presumably, the large non polar portion of these molecules mimics the ___part of lanosterol 14-a-demethylase
non-polar steroidal
Azole SAR:
Imidazole Examples
COMET-K
Clotrimazole
Oxiconazole
Miconazole
Econazole
Tioconazole
-
Ketoconazole
Azole SAR:
TRIAZOLE, Examples
FITVIP
Fluconazole
Itraconazole
Terconazole
Voriconazole
Isavuconazole
Posaconazole
Nucleoside
Flucytosine
MOA: Taken up by ___ and is
converted to 5-fluorouracil which
inhibits thymidylate synthase.
fungi
Nucleoside
____
MOA: Taken up by fungi and is
converted to 5-fluorouracil which
inhibits thymidylate synthase.
Flucytosine
It is an antifungal agent that is Taken with_____ to decrease its resistance.
It is an antifungal agent that is Taken with_____ to
decrease its resistance.
Nucleoside
Flucytosine
MOA: Taken up by fungi and is
converted to ____ which
inhibits thymidylate synthase.
5-fluorouracil
Nucleoside
____
MOA: Taken up by fungi and is
converted to 5-fluorouracil which
inhibits ____
thymidylate synthase.
It is an antifungal agent that is Taken with_____ to
decrease its resistance.
Amphotericin B
__
Generalities: Have one common
structural features – a quinoline ring or a quinoline with an additional benzene added (an acridine ring)
Antimalarial agents
Antimalarial agents
Generalities: Have one common
structural features – a _____ring or a ____ with an additional benzene added (an acridine ring)
quinoline
Antimalarial agents
Generalities: Have one common
structural features – a quinoline ring or a quinoline with an additional ____ added (an acridine ring)
benzene
Used against the Plasmodium
species
Antimalarial agents
Antimalarial agents: is used as____ species
Plasmodium species
Antimalarial agents
Cinchona Alkaloid
______
Quinine’s spectrum of activity is considered to narrow for prophylactic use relative to the synthetic agents.
Quinine and Quinidine
Quinine and Quinidine
of activity is considered to narrow for prophylactic use relative to the synthetic agents.
Quinine’s spectrum
Antimalarial agents
Quinine and Quinidine
Quinine’s spectrum of activity is considered to narrow for ____ relative to the synthetic agents.
prophylactic use
Antimalarial agents
Cinchona Alkaloid: Is still indicated for malaria caused by ___ to other agents like chloroquine
P.falciparum resistant
Antimalarial agents
Side effects of Cinchona Alkaloid
Cinchonism (nausea, vomiting,
tinnitus, and vertigo)
Antimalarial agents
Cinchona Alkaloid: Is still indicated for malaria caused by P.falciparum resistant to other agents lwhat is the ike____
chloroquine
What is the manifestation of Cinchonism
nausea, vomiting, tinnitus, and vertigo
antimalarial agents
Are the closest of the anti-malarial that are based on the quinine structure.
4-aminoquinolines
Antimalarial agents
This group is substituted at the same position 4 as quinine and have an asymmetric carbon equivalent to quinine’s C-9 position
4-aminoquinolines
Just as with quinine, both isomers are active and the 4-aminoquinoline racemic mixtures are used
4-aminoquinolines
considered the prototype of
anti-malaria
Chloroquine & Chloroquine PO4
Antimalarial agents
Chloroquine & Chloroquine PO4 considered the prototype of anti-malarial
HCl- ____
PO4- ____
HCl – parenteral
PO4 – oral
DOC for erythrocytic malaria; also
used in SLE and RA
4-aminoquinolines
4-aminoquinolines is a DOC for
___, ___, and ____.
DOC for erythrocytic malaria; also
used in SLE and RA
____ – the only drug effective against the exoerythrocytic stages of malaria
Primaquine: antimalarial agents
Primaquine: the only drug effective against the ____ stages of malaria
exoerythrocytic
What should be watch out for (WOF) 8-aminoquinolines
WOF: hemolytic anemia – G6PD px
G6PD stands for
Glucose 6 phosphate deficiency
what should be watch out for (WOF) 4-aminoquinolines
▪ WOF: QT Prolongation- affects the heart
Antimalarial agents: Polycyclic Drugs
___ – newest of the
anti-malarial drug from the
natural source of Artemisia
annua
Artemisinin
Antimalarial agents: Polycyclic Drugs
Artemisinin – newest of the
anti-malarial drug from the
natural source of ____
Artemisia annua
Used in DMARD (Demodifying anti-rheumatic drug) and also anti-malarial drug
Hydroxychloroquine
BEQ: What drug has Gemtocidal activity (Vs Vivax, Ovale, Malariae)
Quinine Choloquine
BEQ: drugs that have an activity to Gametocidal (vs. all plasmodium spp.)
Primaquine, Artremisinin
BEQ: drugs that have an activity to tissues schizonticide
Primaquine
BEQ: drugs that have an activity as radical cure
Primaquine
BEQ: drugs that have an activity as prevention of relapse
Primaquine